Methods for Inducing Full Ablation of Hematopoiesis
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,678,491 | Methods for Inducing Full Ablation of Hematopoiesis Inserm (Institut National de la Santé et de la Recherche Médicale), Fondation Imagine, Assistance Publique-Hôpitaux de Paris (Aphp), Université de Paris and Université Toulouse III - Paul Sabatier In force · High confidence | Inserm (Institut National de la Santé et de la Recherche Médicale), Fondation Imagine, Assistance Publique-Hôpitaux de Paris (Aphp), Université de Paris and Université Toulouse III - Paul Sabatier | In force | High confidence |
1 of 1 record shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.